カテゴリ： MarketLine, イギリス, 企業調査

AstraZeneca PLC：企業の戦略・SWOT・財務情報

◆英語タイトル：AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4429
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：69
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report
Summary

AstraZeneca PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AstraZeneca PLC (AstraZeneca or ‘the company’) is global biopharmaceutical company involved in developing, manufacturing and marketing prescription pharmaceuticals. The company provides drugs for three therapeutic areas including oncology, cardiovascular and metabolic disease (CVMD) and respiratory, while selectively pursuing therapies in autoimmunity, infection and neuroscience. The company has three strategic R&D centers located in Gaithersburg, the US; Gothenburg, Sweden; and Cambridge, the UK. Major brands of the company include Faslodex, Zoladex, Tagrisso, Iressa,Symbicort, Pulmicort, Lynparza, Nexium, and Onglyza. The company primarily operates across the Americas, Europe and Asia. AstraZeneca is headquartered in London, the UK.

Scope

- Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
- An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
- Intelligence on AstraZeneca PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AstraZeneca PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
AstraZeneca PLC: Company Overview 9
AstraZeneca PLC: Overview and Key Facts 9
AstraZeneca PLC: Overview 9
AstraZeneca PLC: Key Facts 9
AstraZeneca PLC: Key Employees 11
AstraZeneca PLC: Key Employee Biographies 13
AstraZeneca PLC: Major Products and Services 19
AstraZeneca PLC: Company History 21
AstraZeneca PLC: Management Statement 31
AstraZeneca PLC: Locations and Subsidiaries 33
AstraZeneca PLC: Key Competitors 34
AstraZeneca PLC: Company Analysis 35
AstraZeneca PLC: Business Description 35
AstraZeneca PLC: SWOT Analysis 37
AstraZeneca PLC: SWOT Overview 37
AstraZeneca PLC: Strengths 37
AstraZeneca PLC: Weaknesses 39
AstraZeneca PLC: Opportunities 39
AstraZeneca PLC: Threats 41
AstraZeneca PLC: Corporate Financial Deals Activity 43
AstraZeneca PLC: Financial Deals Overview 43
AstraZeneca PLC: Targets and Partners 45
AstraZeneca PLC: Top Deals 2014 – 2018YTD* 50
AstraZeneca PLC: Advisors 51
AstraZeneca PLC: Top Financial Advisors 51
AstraZeneca PLC: Mergers and Acquisitions 52
AstraZeneca PLC: Corporate Venturing 53
AstraZeneca PLC: Capital Raising 54
AstraZeneca PLC: Partnership 55
AstraZeneca PLC: Divestments 56
AstraZeneca PLC: Recent Developments 57
AstraZeneca PLC: News and Events Summary 57
AstraZeneca PLC: Contracts 61
AstraZeneca PLC: Financial Deals 63
AstraZeneca PLC: Financial Performance 63
AstraZeneca PLC: Market Developments 63
AstraZeneca PLC: Regulatory and Legal Events 65
AstraZeneca PLC: Strategy and Operations 66
Appendix 67
Contact Us 67
Methodology 67
About MarketLine 68

List of Tables
Table 1: AstraZeneca PLC: Key Facts
Table 2: AstraZeneca PLC: Key Employees
Table 3: AstraZeneca PLC: Locations and Subsidiaries
Table 4: AstraZeneca PLC: Key Competitors
Table 5: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Table 7: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Table 9: AstraZeneca PLC: Targets and Partners
Table 10: AstraZeneca PLC: Top Deals 2014 - 2018YTD*
Table 11: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
Table 12: AstraZeneca PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: AstraZeneca PLC: M&A Activity by Geography (2014 - YTD*2018)
Table 14: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: AstraZeneca PLC: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: AstraZeneca PLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: AstraZeneca PLC: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: AstraZeneca PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: AstraZeneca PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: AstraZeneca PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: AstraZeneca PLC: Divestments by Geography (2014 - YTD*2018)
Table 22: AstraZeneca PLC: News and Events Summary
Table 23: AstraZeneca PLC: Contracts
Table 24: AstraZeneca PLC: Financial Deals
Table 25: AstraZeneca PLC: Financial Performance
Table 26: AstraZeneca PLC: Market Developments
Table 27: AstraZeneca PLC: Regulatory and Legal Events
Table 28: AstraZeneca PLC: Strategy and Operations

List of Figures
Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: AstraZeneca PLC: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: AstraZeneca PLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: AstraZeneca PLC: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: AstraZeneca PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: AstraZeneca PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: AstraZeneca PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: AstraZeneca PLC: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[AstraZeneca PLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Guangzhou Improve Medical Instruments Co Ltd (300030)：医療機器：M&Aディール及び事業提携情報
    Summary Guangzhou Improve Medical Instruments Co Ltd (Improve Medical) is a medical devices company that offers medical products, technologies, and services for clinical laboratory and clinical nursing. The company’s products include Improvacuter evacuated blood collection systems, Impromini capilla …
  • Quantum Genomics SA (ALQGC)：企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition ( …
  • Somnomed Ltd (SOM)：医療機器：M&Aディール及び事業提携情報
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • AusGroup Ltd (5GJ)：石油・ガス：M&Aディール及び事業提携情報
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, surfa …
  • Bank of Taiwan：企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alstom SA (ALO)：企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Compania Espanola de Petroleos SAU：企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Idemitsu Kosan Co Ltd (5019)-エネルギー分野：企業M&A・提携分析
    Summary Idemitsu Kosan Co., Ltd. (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. Apart from petroleum products, the company also manufactures agricultural chemicals, agricultural materials, and other chemicals. I …
  • SRF Ltd (SRF)：企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Hargreaves Services Plc：企業の戦略・SWOT・財務分析
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dr. Paul Lohmann GmbH & Co KGaA：企業の戦略・SWOT・財務分析
    Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • University of California San Diego-医療機器分野：企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Aldi Einkauf GmbH & Co oHG：企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Synaffix BV：製薬・医療：M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • CCL Industries Inc.：企業の戦略・SWOT・財務情報
    CCL Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary CCL Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Trumpf GmbH + Co KG：企業の戦略的SWOT分析
    Trumpf GmbH + Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Spinal Elements Inc-医療機器分野：企業M&A・提携分析
    Summary Spinal Elements Inc (Spinal Elements), formerly Quantum Orthopedics Inc, a subsidiary of Amendia Inc, is a medical device company that manufactures spinal implants and instruments. The company provides products such as cervical interbody system, cervical implant system, anterior cervical pla …
  • Advanced Micro Devices, Inc.：企業の戦略・SWOT・財務情報
    Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advanced Micro Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MVV Energie AG (MVV1)：企業の財務・戦略的SWOT分析
    MVV Energie AG (MVV1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dampier Gold Limited：企業の戦略・SWOT・財務分析
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆